Total Payments
$1,500
2024 Payments
$119.46
Companies
20
Transactions
79
Medicare Patients
1,451
Medicare Billing
$186,088
Payment Breakdown by Category
Food & Beverage$1,466 (97.7%)
Other$34.14 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,466 | 77 | 97.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34.14 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $504.27 | 24 | $0 (2024) |
| Biogen, Inc. | $117.38 | 6 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $107.47 | 6 | $0 (2024) |
| Lilly USA, LLC | $93.12 | 5 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $74.42 | 5 | $0 (2021) |
| UCB, Inc. | $70.15 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $65.82 | 4 | $0 (2020) |
| UPSHER-SMITH LABORATORIES LLC | $65.18 | 3 | $0 (2021) |
| Acorda Therapeutics, Inc | $53.01 | 3 | $0 (2023) |
| Allergan, Inc. | $43.30 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $119.46 | 6 | ABBVIE INC. ($69.23) |
| 2023 | $369.04 | 18 | ABBVIE INC. ($145.57) |
| 2022 | $217.30 | 10 | ABBVIE INC. ($217.30) |
| 2021 | $417.52 | 23 | Lilly USA, LLC ($80.26) |
| 2020 | $253.99 | 15 | Novartis Pharmaceuticals Corporation ($65.82) |
| 2019 | $122.65 | 7 | Biogen, Inc. ($59.38) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Central Nervous System | ||||||
| 05/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: PAIN | ||||||
| 04/19/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Neuromodulation | ||||||
| 12/11/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Central Nervous System | ||||||
| 09/25/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Neurology | ||||||
| 09/12/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Neurology | ||||||
| 08/11/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Parkinson's Disease | ||||||
| 08/08/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/04/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Neuropsychiatry | ||||||
| 08/02/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Neuromodulation | ||||||
| 05/09/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: UPLIZNA | ||||||
| 05/04/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Neuroscience | ||||||
| 05/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/06/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Neurology | ||||||
| 02/27/2023 | PFIZER INC. | COMIRNATY (Biological), NURTEC ODT | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: VACCINES | ||||||
| 02/07/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/09/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 298 | 376 | $118,264 | $48,665 |
| 2022 | 7 | 342 | 399 | $99,078 | $32,114 |
| 2021 | 6 | 414 | 501 | $138,721 | $58,056 |
| 2020 | 8 | 397 | 464 | $132,792 | $47,253 |
Total Patients
1,451
Total Services
1,740
Medicare Billing
$186,088
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 171 | 171 | $70,233 | $27,277 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 146 | $31,098 | $13,542 | 43.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 59 | $16,933 | $7,847 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 170 | $35,870 | $12,024 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 71 | 80 | $22,880 | $7,583 | 33.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 45 | 45 | $18,781 | $5,681 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $9,084 | $2,582 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 34 | $4,862 | $1,761 | 36.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 23 | 27 | $5,346 | $1,731 | 32.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 16 | $2,256 | $751.85 | 33.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 146 | 166 | $47,476 | $22,249 | 46.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 115 | 175 | $36,925 | $16,151 | 43.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 95 | 95 | $38,665 | $15,035 | 38.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $6,804 | $2,086 | 30.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 26 | $3,718 | $1,417 | 38.1% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 15 | 18 | $5,133 | $1,119 | 21.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 117 | 117 | $47,619 | $17,110 | 35.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 62 | 83 | $23,738 | $9,505 | 40.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 83 | 117 | $24,687 | $8,317 | 33.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 56 | 56 | $18,144 | $6,553 | 36.1% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2020 | 16 | 21 | $8,463 | $1,652 | 19.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 27 | 29 | $3,813 | $1,594 | 41.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 28 | $4,004 | $1,463 | 36.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 13 | $2,324 | $1,059 | 45.6% |
About Dr. Paula Rauschkolb, DO
Dr. Paula Rauschkolb, DO is a Neurology healthcare provider based in Anthem, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396963914.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paula Rauschkolb, DO has received a total of $1,500 in payments from pharmaceutical and medical device companies, with $119.46 received in 2024. These payments were reported across 79 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,466).
As a Medicare-enrolled provider, Rauschkolb has provided services to 1,451 Medicare beneficiaries, totaling 1,740 services with total Medicare billing of $186,088. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Anthem, AZ
- Active Since 04/20/2007
- Last Updated 01/24/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1396963914
Products in Payments
- QULIPTA (Drug) $283.78
- BOTOX (Biological) $184.59
- AJOVY (Biological) $107.47
- NURTEC ODT (Drug) $89.47
- UBRELVY (Drug) $79.20
- EMGALITY (Drug) $74.89
- ZEPOSIA (Drug) $65.73
- TYSABRI (Biological) $56.51
- INBRIJA (Drug) $53.01
- INFINITY (Device) $41.91
- TOSYMRA (Drug) $41.73
- Aimovig (Biological) $40.27
- Briviact (Drug) $40.17
- AVONEX (Biological) $37.74
- NUPLAZID (Drug) $37.29
- MAYZENT (Drug) $34.23
- INGREZZA (Drug) $26.55
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $23.45
- TECFIDERA (Drug) $23.13
- COMIRNATY (Biological) $22.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.